MAPK3 and Hyperglycemia: Specific modulation of ROS-related hyperglycemia is also an important issue because hyperglycemia inhibits the angiogenic capacity of transplanted cells and resident stem/progenitor cells and suppresses cell homing by regulating the ERK1/2 pathway [9, 21].